Pfizer
Xander Kessler is a finance professional with a strong background in business development and research. Currently serving as a Rotational Finance Manager at Pfizer in Global Biopharma FP&A since July 2024, Xander previously held the role of Business Development Intern at Immuto Scientific and was a Teaching Assistant for Risk Management and Insurance at the Wisconsin School of Business. With experience as an MBA Finance Summer Associate at Pfizer and an intern at Immuto Scientific, Xander has a solid foundation in finance and management. Notably, Xander contributed to significant research at the Institute for Molecular Virology, generating over $60,000 for the lab through experiments related to vaccine studies. Xander holds an MBA in Corporate Finance and Investment Banking from the Wisconsin School of Business and a BS in Biochemistry from the University of Wisconsin-Madison.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.